S3K is an Indo-British pharmaceutical company founded in 2007. The company's slogan "Enhancing human life through quality care" reflects its commitment to providing affordable, high-quality medicines globally. With bases in the United Kingdom and India, S3K manufactures and markets a wide range of API and medicines, including tablets, capsules, injections, syrups, cosmeceuticals, and neutraceuticals. Operating under the guidance of qualified pharmacists and professionals, S3K ensures that all products are manufactured in state-of-the-art, WHO-GMP approved plants in India, adhering to international GMP standards. The company aims to provide access to medicines globally and has operations in Asia, Africa, Central & South America, Caribbean Islands, and CIS countries. The product portfolio of S3K includes innovative formulations and API, reflecting the company's focus on innovation and commitment to excellence. Although specific details about headquarter location and recent investments are not provided, the company's emphasis on quality, accessibility, and global reach positions it as a potential investment opportunity in the pharmaceutical and medical devices industries for venture capitalists looking to support companies dedicated to enhancing human life through healthcare solutions.
There is no investment information
No recent news or press coverage available for S3K.